SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001509190-17-000039
Filing Date
2017-08-04
Accepted
2017-08-04 07:51:13
Documents
79
Period of Report
2017-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q petx-20170630x10q.htm 10-Q 1545559
2 EX-10.3 petx-20170630xex10_3.htm EX-10.3 60915
3 EX-10.4 petx-20170630xex10_4.htm EX-10.4 167918
4 EX-31.1 petx-20170630xex31_1.htm EX-31.1 19951
5 EX-31.2 petx-20170630xex31_2.htm EX-31.2 20283
6 EX-32.1 petx-20170630xex32_1.htm EX-32.1 6796
7 EX-32.2 petx-20170630xex32_2.htm EX-32.2 7496
8 GRAPHIC petx-20170630x10qg001.jpg GRAPHIC 47589
  Complete submission text file 0001509190-17-000039.txt   7070816

Data Files

Seq Description Document Type Size
9 EX-101.INS petx-20170630.xml EX-101.INS 1642027
10 EX-101.SCH petx-20170630.xsd EX-101.SCH 48552
11 EX-101.CAL petx-20170630_cal.xml EX-101.CAL 57615
12 EX-101.DEF petx-20170630_def.xml EX-101.DEF 154263
13 EX-101.LAB petx-20170630_lab.xml EX-101.LAB 357330
14 EX-101.PRE petx-20170630_pre.xml EX-101.PRE 312157
Mailing Address 11400 TOMAHAWK CREEK PARKWAY, SUITE 340 LEAWOOD KS 66211
Business Address 11400 TOMAHAWK CREEK PARKWAY, SUITE 340 LEAWOOD KS 66211 913.353.1000
ARATANA THERAPEUTICS, INC. (Filer) CIK: 0001509190 (see all company filings)

IRS No.: 383826477 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35952 | Film No.: 171006909
SIC: 2834 Pharmaceutical Preparations